When you lose a meaningful amount of it, your resting metabolism can dip, which makes maintaining your new weight harder and can set up the frustrating rebound that so many dieters know well
2021;12:e0212121
Individuals with the following conditions may be at heightened risk and should be assessed carefully: Pre-existing arrhythmias , including atrial fibrillation or supraventricular tachycardia, given the drug's association with elevated resting heart rate Heart failure , particularly where heart rate control is a key management goal Ischaemic heart disease , where any increase in myocardial oxygen demand could be clinically significant Uncontrolled hypertension , although retatrutide may itself reduce blood pressure over time Patients on rate-modifying medications such as beta-blockers or calcium channel blockers whilst no direct pharmacokinetic drugdrug interactions have been established, the heart rate effects of retatrutide may complicate clinical management and require closer monitoring Patients with a recent acute coronary syndrome, decompensated heart failure, or unstable angina are typically excluded from clinical trials of this class of agent

A correlation between severe reduction of GSH levels and PD onset was recently proposed 50
Dosage and Frequency Once a week subqutaneous (Sub-q) Injection, administered in the fatty abdominal area or thigh
The HPG axis , sometimes described as hypothalamic-pituitary-gonadal signaling, governs reproductive hormones